BioLattice Ophthalmics, Inc,

Form D Filings

Location
Philadelphia, PA
Industry Group
Biotechnology
Entity Type
Corporation
CIK
0002125596
All SEC Filings
View on sec.gov
Date Filed Security Types Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
3/30/2026 Equity $575,000 $2,500,000 $1,925,000 3/6/2026 3/30/2026 D 000212559626000001